These results were corroborated by work in MMTV-PyMT transgenic mice and PDXs from ER + breast cancer [60], which modelled hormonal human treatments by administering steroids to mice in a pattern that closely mimics daily oral steroid exposure in women. This evidence concerns the gene ESR1 and breast carcinoma.